CCX-662

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCX-662
Drug Alias NameCXCR7 antagonist (ChemoCentryx)CCX-662
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCXCR7 protein inhibitors
TargetsC-X-C chemokine receptor type 7
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A